Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731542) titled 'Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Asian Institute of Gastroenterology, India
Condition:
Functioanl Dyspepsia
Intervention:
Drug: Vonoprazan plus Itopride combination
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 10, 2026
Target Sample Size: 192
Countries of Recruitment:
India
To know more, visit https://clinicaltrials.gov/study/NCT07731542
Pub...